INVST’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
15,135
-483
-3% -$45.4K 0.15% 112
2026
Q1
$1.46M Sell
15,618
-836
-5% -$81.9K 0.16% 101
2025
Q4
$1.6M Sell
16,454
-73
-0.4% -$6.91K 0.17% 100
2025
Q3
$1.46M Buy
16,527
+352
+2% +$30.4K 0.17% 105
2025
Q2
$1.39M Buy
16,175
+217
+1% +$18.7K 0.17% 103
2025
Q1
$1.46M Buy
+15,958
New +$1.45M 0.2% 92

Other funds holding IXJ

INVST's IXJ Position: Q2 2026 in Review

INVST reduced its iShares Global Healthcare ETF (IXJ) stake by 3.1% in Q2 2026, selling an estimated $45.4K and leaving 15,135 shares worth $1.49M. The position accounts for 0.15% of the portfolio, ranked #112.

INVST first reported a position in IXJ in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.6M in Q4 2025. 301 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • INVST held 15,135 shares of iShares Global Healthcare ETF worth $1.49M as of Q2 2026.
  • INVST sold 483 iShares Global Healthcare ETF shares in Q2 2026, an estimated $45.4K.
  • iShares Global Healthcare ETF made up 0.15% of INVST's portfolio in Q2 2026, its #112 holding.
  • INVST first reported a position in iShares Global Healthcare ETF in Q1 2025 and has held it in 6 quarters since.
  • INVST's iShares Global Healthcare ETF position peaked at $1.6M in Q4 2025.
  • 301 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on INVST's 13F filing for Q2 2026, filed 14 Aug 2026.